Inventor
OUK SAMEDY
US25 patents
⚠️ This page may combine multiple inventors who share the name “OUK SAMEDY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
6 patentsUS7709517B2May 4, 2010
Diarylhydantoin compounds
UNIV CALIFORNIA99 citations98
US9987261B2Jun 5, 2018
Substituted diazaspiroalkanes as androgen receptor modulators
UNIV CALIFORNIA12 citations92
US9388159B2Jul 12, 2016
Substituted diazaspiroalkanes as androgen receptor modulators
UNIV CALIFORNIA15 citations92
US10857139B2Dec 8, 2020
Substituted diazaspiroalkanes as androgen receptor modulators
UNIV CALIFORNIA4 citations84
US7718684B2May 18, 2010
Methods and materials for assessing prostate cancer therapies and compounds
UNIV CALIFORNIA13 citations82
US11771687B2Oct 3, 2023
Substituted diazaspiroalkanes as androgen receptor modulators
UNIV CALIFORNIA0 citations62
ARDEA BIOSCIENCES INC
4 patentsUS8629278B2Jan 14, 2014
Thioacetate compounds, compositions and methods of use
ARDEA BIOSCIENCES INC6 citations84
US8541589B2Sep 24, 2013
Thioacetate compounds, compositions and methods of use
ARDEA BIOSCIENCES INC8 citations84
US10919858B2Feb 16, 2021
Thioacetate compounds, compositions and methods of use
ARDEA BIOSCIENCES INC0 citations62
US8372852B2Feb 12, 2013
Purines as reverse transcriptase inhibitors
ARDEA BIOSCIENCES INC0 citations49
IMMUNETARGET INC
4 patentsUS11266648B2Mar 8, 2022
Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitors
IMMUNETARGET INC1 citations68
US10660894B2May 26, 2020
Small molecule NF-κB inhibitors
IMMUNETARGET INC1 citations68
US10226464B2Mar 12, 2019
Small molecule NF-κB inhibitors
IMMUNETARGET INC2 citations68
US11083729B2Aug 10, 2021
Methods of treating cancer with small molecule NF-κB inhibitors
IMMUNETARGET INC0 citations47
JUNG MICHAEL E
2 patentsUS8445507B2May 21, 2013
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
JUNG MICHAEL E73 citations98
US8802689B2Aug 12, 2014
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
JUNG MICHAEL E25 citations92